Emerging Indications for Hyperbaric Oxygen Treatment
Post-COVID-19 Condition · Ulcerative Colitis · Crohn Disease · Calciphylaxis · Frostbite
Enrolment: 100 · Results not recorded
Procedure
3 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Post-COVID-19 Condition · Ulcerative Colitis · Crohn Disease · Calciphylaxis · Frostbite
Enrolment: 100 · Results not recorded
Neurologic Deficiency · Traumatic Brain Injury
Enrolment: 60 · Results not recorded
Barotrauma
Enrolment: 90 · Results not recorded
Diabetes Mellitus · Chronic Ulcers of the Lower Limb
Enrolment: 107 · Results not recorded
Infectious Endocarditis
Enrolment: 10 · Results not recorded
Laryngeal Cancer
Enrolment: 150 · Results not recorded
Chemical Peeling
Enrolment: 40 · Results not recorded
Neuropathic Diabetic Ulcer - Foot
Enrolment: 40 · Results not recorded
Spinal Anesthesia · Machine Learning · Knee Arthroplasty, Total
Enrolment: 145 · Results not recorded
Overweight and Obesity · Insulin Sensitivity
Enrolment: 12 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: hydrogen sulfide inhalation (300 ppm, 60 min)
Hyperbaric oxygen improved arterial oxygenation and reduced myocardial and lung injury after hydrogen sulfide exposure.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.